Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

The List of Essential Implantable Medical Devices was expanded in Russia in January 2022

26 Jan 2022

On January 14, 2022, the Government of the Russian Federation released a Decree which approved the changes in the List of Essential Implantable Medical Devices. In 2022, the following three new devices were added:

  • 329050 Implantable pulse generator that delivers controlled electrical impulses in urinary/fecal incontinence;
  • 343440 Bioprosthetic aortic valve/xenoprosthesis;
  • 349640 Synthetic embolization material of vessels located outside the brain.

The full details in Russian can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.